Jinkang Hexin Pharmaceutical Co., Ltd., commonly referred to as Jinkang Hexin, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 2005, the company has made significant strides in the development and production of innovative healthcare solutions, particularly in the fields of generic drugs and active pharmaceutical ingredients (APIs). With a strong operational presence across major regions in Asia, Jinkang Hexin is renowned for its commitment to quality and efficacy. The company’s core offerings include a diverse range of pharmaceuticals that cater to various therapeutic areas, setting them apart through rigorous research and development practices. Jinkang Hexin has achieved notable market recognition, positioning itself as a trusted name in the industry, dedicated to enhancing patient outcomes through advanced medicinal products.
How does Jinkang Hexin Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jinkang Hexin Pharmaceutical's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jinkang Hexin Pharmaceutical, headquartered in CN, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing carbon emissions and setting ambitious targets to mitigate climate impact. As such, Jinkang Hexin Pharmaceutical may benefit from establishing clear commitments and measurable goals to enhance their sustainability profile and align with industry standards.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jinkang Hexin Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.